CC0651, a small molecule inhibitor that selectively inhibits CDC34, potently suppresses cell proliferation of several human cancer cell lines; however, there is still a lack of preclinical or clinical information on CC0651 in lung cancer [112]. The gene discussed is CDC34; the disease is lung carcinoma.